Global Botanical and Plant-derived Drugs Markets, 2017-2022: Market will Grow from $29.4 Billion in 2017 to Approx. $39.6 Billion by 2022 with a CAGR of 6.1%

The Global Market for Botanical and Plant-Derived Drugs will Grow from $29.4 Billion in 2017 to around $39.6 Billion by 2022 with a CAGR of 6.1%

Report Includes

This report is an analytical business tool whose primary purpose is to describe the botanical drug industry with the overall plant-derived drug industry as a backdrop and the global market for these drugs going forward.

For the purposes of this report, botanicals are those drugs that are FDA-approved under the botanical drug pathway, while plant-derived drugs are both botanicals as well as other approved drugs that contain a mixture of natural plant-derived and synthetic or semisynthetic substances.

The study's main focus is on legal, prescription-required therapeutic medicines sold in the open market. The study does not specifically cover herbals generally sold as dietary supplements (i.e., to promote overall wellness rather than to address a specific medical condition or symptoms). While there is a substantial market for these products, the medical value of many of these substances has not been demonstrated conclusively.

The Format Of The Study Is Organized Around The Following Topics:

Key Topics Covered:

1: Introduction

2: Summary and Highlights

3: Market and Technology Background

4: Market Breakdown by Technology Type

5: New Developments and Market Opportunities

6: Company Profiles

7: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/4h5lwk/botanical_and

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716